JNJ

NYSE Johnson & Johnson

Oct 24, 2026 · 5:10 AM ET EOD Market Closed

$263.81 ↑ +0.00 (+0.00%) Trading Up from the previous close of $263.81, $2.21 below the day’s high of $266.03

YTD change: +27.48%
vs 20-day SMA: +1.70%
vs 200-day SMA: +7.59%

Price ranges

Previous day

$262.40 $266.03

open $265.82 close $263.81

-$2.01 (-0.76%)

Today

$262.40 $266.03

$263.81

Past week

$251.50 $269.67

from $253.28 now $263.81

+$10.53 (+4.16%)

Past month

$245.17 $273.78

from $270.68 now $263.81

-$6.87 (-2.54%)

This year

$200.91 $281.07

from $206.95 now $263.81

+$56.86 (+27.48%)

Price & Performance

+36.31 (+15.96%) / 6M

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good

The stock is 6.1% away from all-time highs of $281.07
JNJ is up 27% since the beginning of the year
JNJ is up 37% over the past 12 months
JNJ is down 3% over the past 1 month
1% of all JNJ investors are betting against JNJ
Number of investors short JNJ has gone up 2% versus last month

JNJ reads very good: price sits above both the 20- and 200-day averages, short interest is rising month over month, the 12-month move is +38.6%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes

EPS $2.59

Earnings momentum +10.8% Quarterly EPS growth

Quarterly change +10.8%

Valuation

P/E ratio 29.90

Enterprise value $682.7B

Beta 0.00

Balance sheet & scale

Income$16.1M

Revenue$99.3B

Cash$17.2B

Debt$44.7M

Income / Debt 0.36×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNYSE

Sector Manufacturing

Sub Sector Chemical Manufacturing

Market cap $635.8B

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Competitor comparison

Ticker	Company	Price	Change
LLY	Eli Lilly and Company	$1,273.46	-2.54%
ABBV	AbbVie, Inc.	$285.64	+0.16%
MRK	Merck & Co., Inc.	$145.27	-1.34%
RHHBY	Roche Holding Ltd Sponsored ADR	$61.17	+2.60%
NVS	Novartis AG Sponsored ADR	$151.12	-3.30%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.